Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials

被引：0
|
作者：
Yosipovitch, Gil [1 ]
Lio, Peter A. [2 ]
Rosmarin, David [3 ]
Legat, Franz J. [4 ]
Carrascosa, Jose-Manuel [5 ]
Meskimen, Eric [6 ]
Casillas, Marta [6 ]
Pierce, Evangeline [6 ]
Xu, Chenjia [6 ]
Zhong, Jinglin [7 ]
Staender, Sonja [8 ]
机构：
[1] Univ Miami, Miller Sch Med, Coral Gables, FL USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Tufts Univ, Sch Med, Boston, MA USA
[4] Med Univ Graz, Graz, Austria
[5] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[6] Eli Lilly & Co, Indianapolis, IN USA
[7] IQVIA, Rockville, MD USA
[8] Univ Hosp Munster, Munster, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
41916
引用
收藏
页码：AB61 / AB61
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of stapokibart (CM310) in adults with moderate-to- severe atopic dermatitis: A multicenter, randomized, doubleblind, placebo-controlled phase 3 trial
    Zhao, Yan
    Zhang, Litao
    Zhang, Jianzhong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05)
  • [42] Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Asthma: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
    Deleuran, Mette
    Guttman-Yassky, Emma
    Kingo, Kulli
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Akinlade, Bolanle
    Eckert, Laurent
    Gadkari, Abhijit
    Ardeleanu, Marius
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB132 - AB132
  • [43] Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage)
    Warren, Richard B.
    de Bruin-Weller, Marjolein
    Tsianakas, Athanasios
    Khemis, Abdallah
    Szepietowski, Jacek C.
    Hong, H. Chih-Ho
    Armengol, Clara
    Falques, Meritxell
    Agell, Helena
    Massana, Eric
    Gil, Esther Garcia
    Weidinger, Stephan
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [44] Abrocitinib treatment in patients with moderate to severe atopic dermatitis: Consistency of efficacy responses from randomized, controlled phase 3 and phase 2b clinical trials
    Simpson, Eric L.
    Gooderham, Melinda
    King, Brett
    Taylor, Susan C.
    Rosmarin, David
    Tatulych, Svitlana
    Nduaka, Chudy
    Williams, David
    Zhang, Weidong
    Rojo, Ricardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB62 - AB62
  • [45] Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
    Timo Buhl
    David Rosmarin
    Esther Serra-Baldrich
    Pablo Fernandez-Peñas
    Atsuyuki Igarashi
    Maria Polina Konstantinou
    Sherry Chen
    Na Lu
    Evangeline Pierce
    Marta Casillas
    Dermatology and Therapy, 2021, 11 : 971 - 982
  • [46] Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
    Buhl, Timo
    Rosmarin, David
    Serra-Baldrich, Esther
    Fernandez-Penas, Pablo
    Igarashi, Atsuyuki
    Konstantinou, Maria Polina
    Chen, Sherry
    Lu, Na
    Pierce, Evangeline
    Casillas, Marta
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 971 - 982
  • [47] Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Allergic Rhinitis: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
    Thaci, Diamant
    Bieber, Thomas R. M.
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Akinlade, Bolanle
    Eckert, Laurent
    Gadkari, Abhijit
    Ardeleanu, Marius
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB136 - AB136
  • [48] Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
    Simpson, Eric L.
    Lacour, Jean-Philippe
    Silverberg, Jonathan I.
    Worm, Margitta
    Wollenberg, Andreas
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Akinlade, Bolanle
    Eckert, Laurent
    Gadkari, Abhijit
    Ardeleanu, Marius
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB131 - AB131
  • [49] Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)
    Thaci, Diamant
    Simpson, Eric L.
    Deleuran, Mette
    Kataoka, Yoko
    Chen, Zhen
    Gadkari, Abhijit
    Eckert, Laurent
    Akinlade, Bolanle
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2019, 94 (02) : 266 - 275
  • [50] Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials
    Wu, Shuying
    Wang, Huiping
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 601 - 610
12345